{"retracted":false,"update":{"timestamp":1369872000000,"doi":"10.1007/s11102-013-0491-3","type":"correction"},"doi":"10.1007/s11102-013-0478-0","journal":"Pituitary","publisher":"Springer Nature","title":"Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study"}
